05 Apr 2025

Pharma Stocks Tumble Amid Reports of Imminent US Tariffs on Imports

Pharmaceutical sector stocks witnessed a sharp decline after reports emerged that the Trump Administration is set to impose “unprecedented” tariffs on pharmaceutical imports.

Aurobindo Pharma is currently trading at RS. 1112.45, plunging by 63.60 points or 5.41% from its previous close of RS. 1176.05 on the BSE. The stock opened at RS. 1175.00 and recorded a high of RS. 1176.60 and a low of RS. 1049.85. A total of 1,40,673 shares have changed hands so far.

Cipla is trading at RS. 1415.25, down by 79.90 points or 5.34% from its last close of RS. 1495.15. It opened at RS. 1499.25 and hit a high and low of RS. 1499.25 and RS. 1390.35 respectively, with 40,021 shares traded so far.

Lupin has slipped to RS. 1977.75, a decline of 116.75 points or 5.57% from its previous close of RS. 2094.50. The stock opened at RS. 2094.35 and touched a high of RS. 2094.35 and a low of RS. 1918.20. Trading volume stood at 51,714 shares.

Sun Pharmaceutical Industries is trading at RS. 1709.00, down by 61.10 points or 3.45% from its previous close of RS. 1770.10. It opened at RS. 1772.10 and hit a high and low of RS. 1781.70 and RS. 1658.00 respectively. A total of 88,049 shares have been traded so far.

The broader market sentiment in the pharma sector remains cautious amid concerns over escalating trade tensions and policy uncertainty from the US.